Answers are grounded in this paper and cite their sources.
Polyendocrine Metabolic Ovarian Syndrome (PMOS) is an endocrine-metabolic condition with implications that extend beyond gynecological and reproductive health, potentially affecting women's mental health and quality of life. This study aimed to synthesize scientific evidence on the main mental health outcomes among women with PMOS and their associated factors. An integrative literature review was conducted using the PICo framework, with searches performed in MEDLINE via PubMed, Web of Science, Scopus, and LILACS via the Virtual Health Library. Studies published between 2021 and 2026 in Portuguese, English, or Spanish were considered. Study selection was conducted using the Rayyan platform, following PRISMA 2020 recommendations, and evidence levels were classified according to the Joanna Briggs Institute. The search identified 1,614 records, of which 22 studies were included in the final sample. The main outcomes investigated were symptoms of anxiety and depression, along with stress, sleep disturbances, low self-esteem, body image concerns, and impaired quality of life. Associations with clinical, metabolic, hormonal, reproductive, and psychosocial factors were identified, although findings varied across studies. Physical exercise, psychotherapeutic interventions, and vitamin K2 supplementation showed favorable results in specific studies, but methodological limitations were observed. The findings indicate that mental health is an important dimension of care for women with PMOS, highlighting the need for comprehensive healthcare that addresses psychological well-being alongside the physical manifestations of the syndrome.
No takes yet. Share an insight, caveat, or question.
Nobre et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: